The stress hormone cortisol, released when encountering an emotional event, contributes to form a strong emotional memory. Such emotionally arousing memories are recalled with an enhanced subjective sense of recollection, i.e. experienced in memory as more vivid and richer in details. We examined here whether cortisol plays a role in this emotional enhancement in subjective sense of recollection for a set of learned scenes. Suppressing cortisol at encoding decreased the emotional enhancement in subjective sense of recollection at a test 28 h later, but did not affect familiarity and memory for a contextual detail. Individual cortisol levels were significantly correlated to emotional enhancement in subjective sense of recollection. These findings indicate that cortisol plays a modulatory role for enhanced subjective sense of recollection for emotional events.
Introduction
People remember emotional events especially well (Phelps, 2004; Labar & Cabeza, 2006; Roozendaal & McGaugh, 2011) . Encountering an emotional event triggers the release of stress hormones, such as noradrenaline and cortisol, which have been ascribed a major role in the formation of a strong emotional memory (Roozendaal, McEwen, & Chattarji, 2009 ). In particular, the concerted action of noradrenaline and cortisol in amygdala and amygdala-exerted modulation of other memory-related brain regions, such as hippocampus, is thought to underlie the enhanced memory for emotional events (Phelps, 2004; Roozendaal & McGaugh, 2011) . Upon recall, such emotionally arousing memories are more often accompanied with a subjective sense of recollection (Ochsner, 2000; Kensinger & Corkin, 2003; Sharot, Martorella, Delgado, & Phelps, 2007; Phelps & Sharot, 2008) , i.e. the feeling of vividly remembering something as a contextually rich episode of our personal experience (Tulving, 1985; Rajaram, 1993) . However, it is not fully understood why emotional events are recalled with an enhanced subjective sense of recollection.
This emotional enhancement in subjective sense of recollection is particularly modulated by the emotion dimension arousal (Ochsner, 2000; Kensinger & Corkin, 2003) . In contrast to the subjective sense of recollection for neutral images which has been linked to increased activation in parahippocampal cortex and better memory for contextual details (Perfect, Mayes, Downes, & Van Eijk, 1996; Gardiner, Ramponi, & Richardson-Klavehn, 1998; Sharot, Delgado, & Phelps, 2004) , the subjective sense of recollection for emotional memories is distinctly associated with enhanced activation of the amygdala and better memory for some, but not all kinds of details (Sharot et al., 2004; Phelps & Sharot, 2008; Sharot & Yonelinas, 2008; Rimmele, Davachi, Petrov, Dougal, & Phelps, 2011) . In addition, noradrenergic activation of beta-adrenergic receptors contributes to the subjective sense of recollection, as blocking the action of noradrenaline with the beta-adrenergic antagonist propranolol at memory encoding decreases the subjective sense of recollection (Rimmele, Lackovic, Tobe, Leventhal, & Phelps, 2016) . Given that emotional enhancement in subjective sense of recollection depends on arousal, amygdala and noradrenaline action (Sharot et al., 2004; Rimmele et al., 2016) , and emotional enhancement in memory formation moreover requires cortisol (Roozendaal, Okuda, de Quervain, & McGaugh, 2006; van Stegeren et al., 2007) , the question arises whether cortisol plays a role in the increased subjective sense of recollection for emotional events. Some evidence for cortisol playing a role particularly for subjective sense of recollection comes from a study with a post-encoding stressor, where stress-induced cortisol levels during consolidation were associated with increased subjective sense of recollection at a later test (McCullough, Ritchey, Ranganath, & Yonelinas, 2015) .
Here, we aimed to further explore the relation between cortisol and subjective sense of recollection and to disentangle cortisol effects from the generalized stress response, comprising also immediate noradrenergic action (Hermans, Henckens, Joels, & Fernandez, 2014) . To this end, we used a pharmacological intervention to particularly lower cortisol levels at memory formation. In particular, suppressing cortisol with the cortisol synthesis inhibitor, metyrapone, has been previously found to modulate emotional memory (Rimmele, Meier, Lange, & Born, 2010; Marin, Hupbach, Maheu, Nader, & Lupien, 2011; Rimmele, Besedovsky, Lange, & Born, 2015) . If a concerted action of cortisol and noradrenaline is required for higher subjective sense of recollection for emotional events, as found for overall memory accuracy (Roozendaal et al., 2006; de Quervain, Aerni, & Roozendaal, 2007) , we surmise that suppressing cortisol will decrease subjective sense of recollection specifically for emotional scenes -whose presentation usually triggers a galvanic skin conductance response, an indicator of increased arousal linked to noradrenergic activity (Bradley, Greenwald, Petry, & Lang, 1992) . Cortisol suppression is furthermore expected to similarly decrease confidence about emotional memories, commonly associated with subjective sense of recollection (Talarico & Rubin, 2003; Sharot, Verfaellie, & Yonelinas, 2007) .
Subjective sense of recollection is by definition associated with enhanced memory for the context of the remembered events (Tulving, 1985; Rajaram, 1993; Yonelinas, 2002) and has been found to be linked with memory for contextual details (Perfect et al., 1996; Gardiner et al., 1998; Rimmele, Davachi, & Phelps, 2012) . Both stress-induced cortisol increase and cortisol administration have been found to affect contextualization of memories ( van Ast, Cornelisse, Meeter, Joels, & Kindt, 2013 ; van Ast, Cornelisse, Meeter, & Kindt, 2014) . Here, we therefore additionally assessed memory for a contextual detail (color of frame around scene during encoding) in order to test the effect of cortisol suppression on the relation between subjective sense of recollection and memory for a contextual detail.
Methods

Participants
In a randomized, placebo-controlled, double blind, between-subject design we recruited 39 healthy men (19 assigned to the metyrapone group, 20 to the placebo group). The final analysis comprised 17 participants in the metyrapone group (mean age 24.88 ± 5.08 years, mean body mass index 23.07 ± 2.64 kg/m 2 ) and 17 in the placebo group (mean age 24.71 ± 3.98 years, mean body mass index 23.14 ± 3.41 kg/m 2 ). The two groups did not differ in demographic variables, self-reports of trait anxiety and depression (all p > .231; assessed before the Encoding Day; Table 1 ). All participants maintained a regular sleep-wake rhythm, were non-smokers, free of neurological and psychiatric disorders, and not on any medication. All participants provided written informed consent approved by the local ethics committee and were paid for their participation. Two participants in the placebo group and two in the metyrapone group were excluded because of false alarm rate higher than two standard deviations to the mean of their group. Additionally, one participant in the placebo group was excluded because of amylase levels higher than two standard deviations (as potential indicator of high chronic stress and stress reactivity; Nater, Rohleder, Schlotz, Ehlert, & Kirschbaum, 2007) .
Procedure and memory tasks
Participants had an encoding and a retrieval session on two consecutive days, with the interval of 28 h (metyrapone: M = 27.94 ± 2.36 h, placebo: M = 27.88 ± 1.22 h, p = .928; see Fig. 1A ). On the Encoding Day, at 9.00 AM (metyrapone: M = 8.55 AM ± 21 min, placebo: M = 8.57 AM ± 17 min, p = .694) participants took either placebo or 1.5 g metyrapone (HRA Pharma).
Metyrapone reduces cortisol production by inhibiting cortisol synthesis in the adrenal cortex and the dose of 1.5 g employed in our study, has been found to sufficiently lower cortisol levels when administered in the morning and affect later memory (Maheu, Joober, Beaulieu, & Lupien, 2004; Marin et al., 2011; Rimmele et al., 2015) . Encoding of emotional and neutral photos took place 3 h after the oral drug administration, when cortisol levels were significantly suppressed after metyrapone. Salivary cortisol and alpha-amylase were collected on the Encoding Day, just before pill administration and then every 30 min for four hours (see Fig. 1A ). On the Recognition Day, two salivary samples were taken before and after the memory task, for a subset of participants (12 in each group).
During encoding, participants were presented 60 neutral and 60 emotional photos inside a colored frame (blue or yellow) for 2 s each. Photos were taken from the IAPS and NAPS databases (Lang, Bradley, & Cuthbert, 2008; Marchewka, Żurawski, Jednoróg, & Grabowska, 2014) The emotional photos were higher in normative ratings of arousal (M = 6.22 SD = .77; 1 = calm, 9 = excited) and lower in valence (M = 2.90 SD = .58; 1 = unhappy, 9 = happy), compared to the neutral photos (arousal: M = 4.00, SD = .85, valence: M = 5.36, SD = .29). Participants had to make a yes/no judgment according to the color of the frame: if the frame color was yellow, participants were asked to judge whether the photo depicted something living or not. If the frame color was blue, participants had to judge whether one would find the content of the photo in a house (Ghetti, Mirandola, Angelini, Cornoldi, & Ciaramelli, 2011) .
At the recognition test 28 h later, the 120 encoded photos were presented intermixed with 120 new photos and participants had to make three judgements for each photo. For the first judgment, participants were asked to provide a Remember response (R), if the presented photo brought back to mind a vivid memory accompanied by details of the encoding episode (subjective sense of recollection), a Know response (K), if the photo was recognized as previously seen but There were no differences between the two groups in all demographics, time interval between encoding and recognition task (all p > .231), and measures of working memory, mood, alertness, calmness, positive and negative affect, and attention tested an hour after metyrapone/placebo administration (all p > .118).
Values depict means ± standard deviation.
not accompanied by episodic detail (familiarity), or a New response for photos not previously seen (Tulving, 1985; Rajaram, 1993; Yonelinas, 2002) . For the second judgment, participants had to report their level of confidence (1 = low; 2 = medium; 3 = high confidence). Third, if a photo had been judged as R or K, participants had to indicate whether the color of the frame around the scene at encoding had been blue or yellow or press "I don't know the color".
Control variables
At the Encoding Day, one hour after metyrapone/placebo administration participants were tested for their working memory, mood, alertness, calmness, positive and negative affect, and attention. Working memory was assessed with the Digit Span subtest (forward and backward) of the Wechsler Adult Intelligence Scale (Wechsler, 1981) ; mood, alertness and calmness with the Multidimensional Mood Questionnaire (Steyer, Schwenkmezger, Notz, & Eid, 1997) ; positive and negative affect with the Positive and Negative Affect Scale, PANAS (Watson, Clark, & Tellegen, 1988) ; and attention with the d2 letter cancellation test (Brickenkamp & Zillmer, 1998) . Participants further performed other cognitive tasks, which have not been analysed and will not be included here.
Data analyses
Cortisol and amylase levels were analysed with mixed-design analyses of variance (ANOVAs) with metyrapone/placebo group as a between-subject factor and 8 time-points of saliva samples on Encoding Day (and 2 on Recognition Day) as repeated-measures factor "time", with Greenhouse-Geisser corrections of degrees of freedom if appropriate and follow-up tests to specify significant differences (all twotailed and considered significant when p ≤ .05). Subjective sense of recollection was calculated as Rhits-Rfalse alarms, familiarity was calculated as Independent K = [(Khits/(1-Rhits))-(Kfalse alarms/(1-Rfalse alarms))], overall recognition memory as RKhits-RKfalse alarms. Memory for a contextual detail was calculated as the rate of Rhits associated with correct memory for the detail (Rhits with correct detail/ Rhits; Rimmele et al., 2011) . Emotional enhancement in memory was calculated with "emotional difference scores", i.e. performance for emotional stimuli minus performance for neutral stimuli (Hamann, Ely, Grafton, & Kilts, 1999; Wagner, Degirmenci, Drosopoulos, Perras, & Born, 2005; Sharot, Verfaellie, et al., 2007) and analysed with one-way independent ANOVA with metyrapone/placebo group as a between subject factor. To examine the relation between cortisol levels and emotional memory enhancement, the area under the curve with respect to ground index was calculated for each participant for cortisol levels during the encoding session (Pruessner, Kirschbaum, Meinlschmid, & Fig. 1 . Experimental procedure (A) and Cortisol Levels (B). (A) Experimental procedure: During Encoding, 3 h after metyrapone/placebo administration, participants saw 60 emotional and 60 neutral photos presented intermixed in six blocks of 20 photos. In three blocks, photos were surrounded by a yellow frame, indicating that participants should answer the question living or non-living when looking at the photo. In the other three blocks photos were presented within a blue frame indicating that they had to respond to the question "Can you find it in a house?". Recognition Session, 28 h later, participants saw old and new photos intermixed and gave three judgment for each photo:
(1) Remember/Know/New judgment, (2) a confidence judgment (1 = low; 2 = medium; 3 = high confidence), and (3) for photos indicated as seen, the color of the frame (blue, yellow or "I don't know the color"). (B) Cortisol levels: Mean ± SEM salivary cortisol concentration for the day of Encoding and Recognition. Horizontal bar indicates the time in min after metyrapone/placebo administration (point 0) for Encoding Day, and before and after the Recognition task for Recognition Day. Metyrapone (black squares) suppressed cortisol levels an hour after pill administration and during Encoding Session (all p < .001), but not at Recognition Session next day (all p > .588). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Hellhammer, 2003) and correlated with emotional memory enhancement measures (van Ast et al., 2014) .
Results
Hormonal measures
As expected, salivary cortisol levels were suppressed in the metyrapone group compared to placebo on the Encoding Day [time by metyrapone/placebo group interaction: F(1.59, 49.22) = 5.013, p = .016, η 2 = .139; main effect of metyrapone/placebo group: F(1, 31) = 21.210, p < .001, η 2 = .406; main effect of time: F(1.59, 49.22) = 59.274, p < .001, η 2 = .657; Fig. 1B ]. Baseline cortisol levels, i.e. salivary cortisol levels immediately before drug administration did not differ between the placebo group (M = 8.50 ± 4.23 μg/dl) and the metyrapone group (M = 8.61 ± 4.33 μg/dl, t(32) = .077, p = .939), as well as 30 min after pill administration (t(32) = −.312, p = .757). For all other measurement times (60-210 min after pill administration), the metyrapone group had significantly lower cortisol levels in comparison to placebo group (all p < .001), crucially also during the encoding task (180-210 min after administration, p < .001). The next day, there was no difference in cortisol levels between the metyrapone and cortisol group before and after the recognition task (all p > .588; see Fig. 1B ).
On the Encoding Day, salivary alpha-amylase levels significantly increased over time [main effect of time: F(4.342, 751479.24) = 5.227, p < .001, η 2 = .157], but they were not affected by metyrapone ([F (4.342, 751479 .24) = 2.082, p = .082, η 2 = .069] for time by group interaction; [F(1, 28) = 1.527, p = .227, η 2 = .052] for main effect of group). There was also no difference between amylase levels on the Recognition Day (all p > .775).
Control variables
Cortisol suppression did not affect measures of reported mood, alertness and calmness (all p > .294), nor measures of attention and working memory at the Encoding Day (all p > .118; see Table 1 for control variables). Participants were able to correctly identify whether they had metyrapone or placebo, based on a questionnaire administered at the end of the encoding session [χ 2 (1) = 10.804, p = .002].
Memory
Most importantly, cortisol suppression decreased the emotional enhancement in response-bias corrected Remember responses [Rhits -Rfalse alarms; placebo: M = .11, SE = .03 vs. metyrapone: M = .03, SE = .02; F(1, 32) = 5.341, p = .027, ω = .364; Fig. 2A ; for separate R hit rate and R fa rate see Supplementary Tables 1 and 2 ]. Emotional enhancement in high confidence hits was not affected by cortisol suppression [placebo: M = .09, SE = .03 vs. metyrapone: M = .03, SE = .02; F(1, 32) = 3.226, p = .082, ω = .25; Fig. 2A ]. Moreover, individual cortisol levels were significantly correlated with the emotional enhancement in subjective sense of recollection (r = .387, p = .024; Fig. 2B ).
On the contrary, familiarity [(Khits/(1-Rhits))-(Kfalse alarms/(1-Rfalse alarms)); for separate K hit rate and K fa rate see Supplementary  Tables 1 and 2] and memory for a contextual detail (color of the frame around scene at encoding) did not differ between the metyrapone and the placebo group (all p > .216). Individual cortisol levels were not related to familiarity and memory for a contextual detail (frame color; all p > .248).
Collapsing across Remember and Know responses to assess overall recognition memory (RKhits -RKfalse alarms) yielded no differences in overall recognition memory between the metyrapone and the placebo group (all p > .232; for separate RK hit rate and RK fa rate see Supplementary Tables 1 and 2) .
Discussion
With this study, we replicate the well-observed emotional enhancement in subjective sense of recollection (Ochsner, 2000; Kensinger & Corkin, 2003; Sharot et al., 2004; Sharot & Yonelinas, 2008; Rimmele et al., 2011 Rimmele et al., , 2012 Boywitt, 2015) . In accordance with previous studies we find that cortisol synthesis inhibitor metyrapone lowers cortisol levels (Maheu et al., 2004; Marin et al., 2011; Rimmele et al., 2015) , and does not affect amylase levels. Crucially, we moreover show that cortisol suppression particularly reduces this emotional enhancement in subjective sense of recollection. This finding demonstrates that the enhancement of subjective sense of recollection for emotional scenes requires sufficient cortisol levels to emerge and thus extends previous work on understanding the role of cortisol in emotional memory formation (Maheu et al., 2004; Maheu, Joober, & Lupien, 2005; Wagner et al., 2005; Roozendaal et al., 2006) .
In contrast to its effect on subjective sense of recollection, we found that cortisol suppression had no effect on the emotional enhancement in high confidence hits. This finding indicates that even though sufficient cortisol contributes to the enhanced emotional subjective sense of recollection, it does not similarly affect high confidence hits.
Corroborating the crucial role of cortisol in emotional memory enhancement, we found that individual cortisol levels are significantly correlated with the emotional enhancement in subjective sense of recollection. These findings suggest that the amount of cortisol at the time of memory formation contributes to the later enhancement in subjective recollection of emotional vs. neutral memories.
While cortisol levels modulate the subjective sense of recollection for emotional scenes, cortisol suppression during memory formation did not affect familiarity. Interestingly, post-encoding stress has been reported to increase later familiarity for neutral scenes (Yonelinas, Parks, Koen, Jorgenson, & Mendoza, 2011; McCullough & Yonelinas, 2013; McCullough et al., 2015) . Thereby, the stress-induced cortisol increases are linearly related to increases in familiarity (McCullough et al., 2015) . But in contrast to these studies investigating memory for stress-induced cortisol increase after encoding, in our study we examined memory for pharmacologically decreased cortisol levels during encoding. Future studies are needed to determine the specifics of the relation between cortisol levels at different memory phases and recollection/familiarity.
This study moreover shows that the reduced emotional enhancement in subjective sense of recollection under cortisol suppression is not due to changes in memory for a specific contextual detail or overall memory, as cortisol suppression neither affected memory for a contextual detail (memory for the color of the frame around the scene at encoding) nor overall memory. Indeed, subjective sense of recollection was equally often accompanied with correct memory for details in both placebo and metyrapone group. As such, it is unlikely that cortisol suppression decreased subjective sense of recollection by affecting the binding between this contextual detail and the scene during encoding. This may also be due to the type of contextual detail assessed in this study: emotional memory enhancement has been distinctly associated with better memory for intrinsic and central details, sometimes at the expense of the memory for extrinsic and peripheral details, such as the color of a frame around a scene (Mather, 2007; Kensinger, 2009; Rimmele et al., 2011) . Moreover, the finding that cortisol suppression did not overall affect memory but particularly decreased the emotional enhancement in subjective sense of recollection demonstrates that cortisol plays a specific role for the subjective recollection part of the emotional memory enhancement.
A potential explanation for the specificity of the observed effects may lie in a crucial interaction of cortisol levels and arousal during encoding. Cortisol has been ascribed a modulatory role on arousal-and amygdala-dependent noradrenergic action leading to enhanced emotional memory formation (Okuda, Roozendaal, & McGaugh, 2004; van Stegeren et al., 2007; Kukolja, Klingmuller, Maier, Fink, & Hurlemann, 2011; Segal et al., 2014) . While increased arousal during encoding has been specifically related to the increase of the subjective sense of recollection (Ochsner, 2000; Kensinger & Corkin, 2004; Rimmele et al., 2016) , it has never been examined whether both cortisol and arousal specifically affect the subjective sense of recollection. Our finding that cortisol suppression particularly reduces the emotional enhancement in subjective sense of recollection suggests that cortisol is necessary for the arousal effects to emerge on enhancing subjective sense of recollection for emotional memories.
Cortisol suppression has been previously found to impair emotional memory retrieval (Rimmele et al., 2010; Marin et al., 2011; Rimmele et al., 2015) . However, given that retrieval took place a day after encoding (28 h later), when the cortisol levels of the two groups were comparable, it seems unlikely that that the lack of emotional enhancement in subjective sense of recollection in the present study is due to metyrapone affecting retrieval. We rather suggest that this finding is due to metyrapone affecting memory formation, during which cortisol levels were clearly suppressed. Cortisol suppression at memory encoding may have affected the involvement of brain regions necessary for the formation of emotional memories associated with subjective sense of recollection, such as the amygdala, and therefore altered the building of emotional memory representations (Sharot et al., 2004; Dolcos, LaBar, & Cabeza, 2005; Sharot, Martorella, et al., 2007) .
A notable limitation of this study is the inclusion of only male participants. To our knowledge, the effects of metyrapone on memory have only been studied on male participants (Lupien et al., 2002; Maheu et al., 2004; Maheu et al., 2005; Rimmele et al., 2010; Marin et al., 2011; Rimmele et al., 2015) . Given that there are gender differences in stress reactivity comprising different cortisol reactivity, and given the complex interaction of sex hormones with cortisol reactivity modulating memory (Merz & Wolf, 2017; Shields, Sazma, McCullough, & Yonelinas, 2017) , future studies need to address how metyrapone affects memory in women. Another limitation of this study is the timing of metyrapone/placebo administration in relation to circadian circulating cortisol levels and the potential effects of this interaction on memory. Metyrapone and placebo group did not differ in terms of the timing of pill administration and of baseline cortisol levels. Metyrapone administration robustly reduced cortisol levels by the time of the encoding. Nevertheless, the observed effects of cortisol suppression on memory cannot be generalized to metyrapone effects on memory on other times of the day. For example metyrapone might exert different effect if administered in the afternoon, i.e. at the nadir of circadian cortisol levels. As such, future studies should determine the details of the interaction of the timing of metyrapone/placebo administration and circulating circadian cortisol levels and how such interaction may distinctly affect memory.
Conclusions
In conclusion, we found that lowering cortisol at encoding particularly decreases the emotional enhancement in subjective sense of recollection, without affecting familiarity, memory for a contextual detail or overall recognition memory. Moreover, individual cortisol levels were significantly correlated with the emotional enhancement in subjective sense of recollection. These findings highlight the role of cortisol for the enhanced subjective sense of recollection for emotional events.
